Emeren Group Ltd. Sponsored ADR (SOL)
(Delayed Data from NYSE)
$1.70 USD
-0.07 (-3.96%)
Updated Jul 24, 2024 04:00 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
Income Statements
Fiscal Year end for Emeren Group Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 105 | 61 | 80 | 74 | 119 |
Cost Of Goods | 81 | 46 | 48 | 57 | 85 |
Gross Profit | 23 | 15 | 31 | 17 | 34 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 18 | 19 | 10 | 35 |
Income After Depreciation & Amortization | -8 | -3 | 13 | 7 | -1 |
Non-Operating Income | -1 | 3 | 0 | 2 | 0 |
Interest Expense | 0 | 3 | 5 | 6 | 9 |
Pretax Income | -9 | -3 | 7 | 2 | -11 |
Income Taxes | 3 | 2 | 1 | 0 | 1 |
Minority Interest | -2 | 0 | 0 | -1 | -3 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -12 | -5 | 7 | 2 | -12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -5 | 7 | 3 | -9 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | 4 | 19 | 14 | 7 |
Depreciation & Amortization (Cash Flow) | NA | 7 | 7 | 7 | 8 |
Income After Depreciation & Amortization | -8 | -3 | 13 | 7 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.53 | 65.47 | 69.50 | 49.79 | 40.60 |
Diluted EPS Before Non-Recurring Items | 0.02 | 0.06 | 0.17 | 0.09 | 0.35 |
Diluted Net EPS (GAAP) | -0.16 | -0.07 | 0.10 | 0.06 | -0.22 |
Fiscal Year end for Emeren Group Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 14.79 | 44.00 | 13.95 | 33.85 |
Cost Of Goods | NA | 10.76 | 40.66 | 8.26 | 21.18 |
Gross Profit | NA | 4.03 | 3.34 | 5.69 | 12.66 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.71 | 9.49 | 9.64 | 7.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.68 | -6.15 | -3.95 | 5.04 |
Non-Operating Income | NA | -3.11 | -1.35 | -4.73 | 2.22 |
Interest Expense | NA | NA | 0.25 | 0.08 | -0.38 |
Pretax Income | NA | -3.80 | -7.74 | -8.77 | 7.65 |
Income Taxes | NA | 0.18 | 2.12 | 0.25 | -0.04 |
Minority Interest | NA | 0.43 | -1.77 | 0.37 | -0.67 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.97 | -8.09 | -9.02 | 7.68 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -4.40 | -8.09 | -9.39 | 8.35 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 53.54 | 55.20 | 56.29 | 57.23 |
Diluted EPS Before Non-Recurring Items | NA | -0.08 | -0.15 | 0.01 | 0.14 |
Diluted Net EPS (GAAP) | NA | -0.08 | -0.15 | -0.17 | 0.14 |